Corvus Pharmaceuticals Inc buy Jefferies Financial Group Inc.
Start price
22.01.26
/
50%
€21.55
Target price
22.01.27
-
Performance (%)
-47.15%
Price
31.07.26
€11.12
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ for Corvus Pharmaceuticals Inc is performing very badly with a performance of -47.15%. This prediction currently runs until 22.01.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corvus Pharmaceuticals Inc | -4.387% | -4.387% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for CRVS provided by MarketBeat